working
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes, I agree, but what news?
We are in a phase II trial with humans, in the recruitment phase and double blind
I think that except for recruitment figures right now we can have little else. IMO
it seems that everything revolves around COVID here,
in the last months not a single PR with another matter
What kind of news?
Has the recruitment already ended?
We will not have news of the study, it is soon and also "blind"
https://www.sidley.com/en/insights/newsupdates/2020/10/sec-issues-compliance-deadline-guidance-on-permitted-collateral-arrangements-for-fully-paid
Yesterday was April 22.
In other biotechnology stocks we have had two days of strong increases, here nothing has been noticed
Actually our problem is only short handling?
the truth is that I do not understand very well why 80% of the test in Russia,
Russia has 3 vaccines and no one gets them, no regulatory agency approves them for lack of documentation, transparency
OTC is OTC for everything, so it seems strange to me that no group pumps this
He has been announcing good things for months,
that's the problem, any other company would be above 1$
By the way, "only" the conspiracy theory is not worth me
Estimated Primary Completion Date : July 2021
Estimated Study Completion Date : July 2021
because they are the same date
I don't think Russia is the best place to do these tests,
They have 3 vaccines and it is put in three counted countries,
They do not send documentation to regulatory agencies for approval
Why not Europe and if Russia?
And assuming the test ends and is successful ...
After?
The sputnik vaccine is not approved by the European Medicines Agency because the trials are not sent to the European Union, no one trusts these "hidden" trials.
Only a few countries: Czech Republic, Hungary ... they are putting it without any kind of approval, and Czech Republic had to return it.
And if the Russians say Ok, after what?
BAB* has no business, not a single news item in years ... that envy!
Aspire with 87k vol ?. LOL
I answer him: he does not have
why don't you sell?
it would be just as logical
Time is running out for those who want cheap stocks
soon they will "fight" for brilacidina
Sorry, spelling mistake
I agree
"...wait for the Current clinical trial results...which dosing has been authorized to increase from 3 to 5 days of dosing to match Remdesivir protocol of 5 days and SoC in many U.S hospitals.
...THEN YOU CAN FOLLOW THE MONEY!!! (but of course, at a much greater price)"
We would like to hear from you every day about the trial, but IT IS IMPOSSIBLE
These things take your time and discretion
Aspire? 85k volume LOL
JANE is not in LEVEL 2 of Ipix any day
...If Brilacidin goes on to realize its promise as a broad spectrum antiviral, the potential benefits to patients and shareholders for this drug would likely be greater than I or anyone could have ever imagined...
selling huge blocks?...LOL
nothing affects the price and volume?
Russian trial...
I do not rule out see 0.20-23 $
This is nonsense, WE ARE IN PHASE II, only speculation should lead us to dollars
despicable, and I'm going to shut up what I think of you and your comments
terrible message, totally depreciable, EVERYONE HAS THE RIGHT TO LIVE
OK, thanks for the clarification
Viewing the study phases (from clinicaltrials.gov) ...
silly question of the week:
Are we really putting a dose or are we just recruiting individuals?
Perhaps this is the reason for the lack of a strong interest, there is still much ahead?
Contract status:
Not yet recruited: The study has not started recruiting participants.
Recruitment:the study is currently recruiting participants. (HERE WE ARE NOW)
Enrollment by invitation: the study selects its participants from a population, or group of people, decided by the researchers beforehand. These studies are not open to everyone who meets the eligibility criteria, but only to people from that particular population, who are specifically invited to participate.
Active, no recruitment: The study is ongoing and participants are receiving an intervention or are being screened, but potential participants are not currently being recruited or enrolled.
Suspended - The study was stopped early, but you can start over.
Completed: The study was stopped early and will not start again. The participants are no longer being tested or treated.
Completed - The study has ended normally and the participants are no longer being examined or treated (that is, the last visit of the last participant has occurred).
Withdrawn: The study was stopped before enrolling its first participant.
Unknown: A study on ClinicalTrials.gov whose last known status was recruitment; you are not recruiting yet; or active, not recruiting but past their end date, and status has not been last verified in the last 2 years.
what is the update, I can not see?
no news is necessary, we have enough to not be at these prices
we will see...
we go green?
dolars coming